ReviewFrontiers in cell and developmental biology2026
Craniofacial and dental toxicity of dioxins: developmental phenotypes and mechanistic insights.
Review in Frontiers in cell and developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Dioxins are persistent environmental pollutants with high lipophilicity and long half-lives, enabling their accumulation in biological tissues and ecosystems. Among them, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is the most toxic and extensively studied chemical. Human exposure occurs primarily through contaminated food, cigarette smoke, and industrial emissions, posing significant health risks. Objective: This review summarizes the effects of dioxins, particularly TCDD, on craniofacial and dental development and discusses recent findings on the mechanisms underlying these effects. Methods: A narrative review of experimental studies in animal models, Results: In the developing palate, TCDD impairs mesenchymal proliferation, shelf elevation, and fusion, resulting in cleft palate involving various mechanisms such as oxidative stress, apoptosis, epigenetic changes, and suppression of TGF-β and Wnt signaling. Craniofacial bone development is also affected, with reduced ossification, altered mineralization, and impaired osteoblast differentiation. These outcomes are largely mediated by aberrant aryl hydrocarbon receptor (AhR) activation. However, other pathways, such as retinoic acid and vitamin D signaling, have also been found to have roles in these outcomes. Furthermore, genetic background modulates susceptibility, as shown by strain-specific differences and the protective role of AhR repressors. TCDD disrupts odontogenesis in a stage- and dose-dependent manner, leading to enamel hypoplasia, molar agenesis, dentin defects, and increased caries susceptibility. Conclusion: Dioxins, particularly TCDD, are potent developmental toxicants affecting multiple craniofacial tissues. Their effects are driven by dysregulation of several critical signaling pathways, with AhR acting as the central mediator. Given their long half-life and bioaccumulation, dioxins remain a relevant public health threat.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.